Make srikumar as your homepage

< >

   
 
Please check "WHAT IS NEW?"  to see new pages we are adding. Enjoy

CAD Free stuff | NRI | Jobs | Home pages Education | Kids | Movies | Games | Music | Indian Music | A  to Z topics | Science| Job Posting | What is New? |

 Engineering| Alumni | Health | Sports |Tourism |Computers | Business | Oman 123| 3D perspectives | Chat Free downloads |Shopping | Family | Comments
Articles| Advertising | Cooking | Humour | Interior Design| Marketing |Toastmasters
 

 
Home
Art of Living
CAD
Cooking
Education
Engineering
Freestuff
Feng Shui
 
< >
 
Festivals
Games
Health
Question papers
Humour
House plans
Jobs
Interior Design
 
Jokes
Kids
Music
Movies
NRI
Oman123
 

Contact:
L.Srikumar Pai
B.Sc( Engg.), MIE, MIWWA, MICI
Civil Engineer & CAD Specialist
Web master

See my 3d perspectives using AutoCAD & 3DS Max.
3D Album
New

 

Blood test could identify lung cancer
Main Article page | Health page| Fitness articles| Diseases

 

Washington,  (ANI): A simple blood test could identify lung cancer patients who will respond positively to the drug erlotinib, reveals a new study.

The researchers found that testing for the presence of specific cancer protein 'fingerprints' in the blood of lung cancer patients may be a useful means of identifying a subgroup whose tumours are more likely to shrink when treated with erlotinib, especially when other testing methods are unavailable.

Erlotinib is one of a class of drugs that specifically inhibits an important cell-surface molecule known as the epidermal growth factor receptor (EGFR), which is highly expressed in some forms of cancer, including lung cancer.

By blocking this receptor, drugs such as erlotinib aim to slow tumour growth and proliferation.

Prof David Carbone from Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, and Canadian colleagues analysed blood samples from the NCIC Clinical Trials Group (NCIC CTG) BR.21 study.

The study had shown that erlotinib improved survival compared to placebo in patients with advanced non-small-cell lung cancer who had already tried one or two other drugs.

In the new study, the researchers analysed blood samples that had been taken from some patients before they started treatment in the BR.21 study.

They performed this analysis on patients who received the drug and on patients who received the placebo, looking for specific proteomic profiles already known to predict outcomes in patients treated with EGFR-blockers.

"The bottom line is that the proteomic test-comparing 'good' and 'poor' profiles-was strongly prognostic in both erlotinib and placebo arms. Proteomics 'good' patients also had a significantly higher response rate than proteomics 'poor' patients," said Carbone.

Carbone has noted that there are other methods available to analyse the EGFR pathway of lung cancers, including sequencing of the EGFR gene, or a technique known as fluorescence in-situ hybridization (FISH) to assess EGFR gene copy number, in which tumour tissue samples are directly studied under a microscope.

"FISH overall was a better predictor of benefit, but can only be done with adequate biopsy tissue, which was available in this study only in 22pct of patients. With the serum test, 99pct of patients had a successful determination of proteomic status,' said Carbone.

"Thus, I think this test may be of potential value in identifying a subgroup of patients with a good prognosis and who are likely to have response to erlotinib; it may be of particular value for those in whom tumor tissue is inadequate or unavailable," added Carbone.

The study was presented at the 2nd European Lung Cancer Conference in Geneva, Switzerland. (ANI)

 
Contact
Personality
Reiki
Real Estate 
Stories
TV
Toastmaster 
Vaastushastra
What is New?
 
< >
 
Free MP3
Results
AutoCAD Blocks
3D Max textures
Printer Drivers
Entrance Test
IAS Topper
 
Public Speaking
Shopping
Translation
Tourism
Useful articles
 
 
 
 
 

 

 
We have provided links for the public use and not responsible for the contents of any site.

About us | Submit your site |Suggestions | A to Z topics |Advertising | Auctions | Alumni | Arts | Astrology | Animals | BusinessCooking CAD| Chat | Computers | Disabled People
Environment | Education | Engineering | Family | Festivals | Freebies | Fun | Games | Health | India | Jobs | Jokes |Kerala | Kids | NRI News |   Movies | Music | Medicine 
| Photography | Religion | Reference | Science | Shopping | Sports | Tenders | Tourism | Vaastu shastra | Women | World | Zoo
Copyright www.srikumar.com 2009-2010